$CB Cashflow Statement | Understand Stock

$CB

$356.18 -$0.56 (0.16%) Live

$CB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements Of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net income
Adjustments to reconcile net income to net cash flows from operating activities
Net Realized Gains Losses
Market Risk Benefit, Change in Fair Value, Gain (Loss)
Accretion (Amortization) of Discounts and Premiums, Investments
Amortization of purchased intangibles
Deferred income taxes
Equity in net income of subsidiaries and affiliates
Unpaid losses and loss expenses
Unearned premiums
Future policy benefits
Insurance and reinsurance balances payable
Accounts payable, accrued expenses, and other liabilities
Income taxes
Insurance and reinsurance balances receivable
Reinsurance recoverable
Deferred policy acquisition costs
Net sales of investments by consolidated investment products
Other
Net Cash Provided by (Used) in Operating Activities, Total
Cash flows from investing activities
Purchases of fixed maturities available-for-sale
Purchases of fixed maturities held-to-maturity
Purchases of equity securities
Sales of fixed maturities available-for-sale
Sales of to be announced mortgage-backed securities
Sales of equity securities
Maturities and redemptions of fixed maturities available-for-sale
Maturities and redemptions of fixed maturities held-to-maturity
Net change in short-term investments
Net derivative instruments settlements
Private equity contributions
Private equity distributions
Acquisition of subsidiaries (net of cash acquired of $32, nil, and $560)
Payment, including deposit, for Huatai Group Interest
Cash And Cash Equivalents Increase (Decrease) Due To Consolidation And Deconsolidation Of Investment Products
Other
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation

Cash flows from financing activities
Dividends paid on Common Shares
Common Shares repurchased
Proceeds from issuance of long-term debt
Repayments of Long-term Debt
Proceeds from share-based compensation plans
Policyholder contract deposits
Policyholder contract withdrawals
Third-party capital invested into consolidated investment products
Third-party capital distributed by consolidated investment products
Proceeds from issuance of repurchase agreements
Repayment of repurchase agreements
Tax withholding payments for share-based compensation plans
Net cash flows (used for) from financing activities
Effect of foreign currency rate changes on cash and restricted cash
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Cash and restricted cash - beginning of year
Cash and restricted cash - end of year
Supplemental cash flow information
Taxes paid
Interest paid
Net income

Comments